Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR of 10.7%. Growth in cancer profiling market is driven by increasing number of cancer cases, growing utility of biomarker in tumor profiling, and availability of funding for cancer research.
In cancer profiling market research addition, introduction and adoption of point-of-care diagnostic tests and development of personalized medicine are expected to offer growth opportunities for manufacturers of cancer/tumor profiling solutions.
Access Sample Copy of Cancer Profiling Market spread across 155 Pages, Profiling 11 Companies and Supported with 67 Tables and 32 Figures is now available at www.reportsnreports.com/contacts/r….aspx?name=268825 .
Cancer profiling market dominated by established players Illumina (US), QIAGEN (Netherlands), Neo Genomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). Cancer profiling market in this report is segmented by cancer type, application, technology, and region.
Study tracks and analyzes competitive developments like product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players & core competencies in cancer profiling market.
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)
1 Illumina, Inc.
2 Qiagen N.V.
3 Neogenomics Laboratories, Inc.
4 HTG Molecular Diagnostics, Inc.
5 Genomic Health Inc.
6 Caris Life Sciences
7 Helomics Corporation
8 Nanostring Technologies, Inc.
9 Oxford Gene Technology
10 Ribomed Biotechnologies, Inc.
Global cancer profiling market broadly divided into immunoassays, hybridization, NGS, mass spectrometry, & other technologies. In 2017, immunoassays segment is expected to account for largest share of cancer profiling technologies market.
High sensitivity & cost-effectiveness of these techniques and technological advancements in these immunoassays tests are factors that are expected to propel growth of this market in coming years.
Access More Information on Cancer Profiling Market with Top Trends, Forecast, Analysis and Overview at www.reportsnreports.com/contacts/i….aspx?name=268825 .
Cancer profiling market in this report is segmented by cancer type, application, technology, and region. On basis of cancer type, cancer type market is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, & cancer types.
In 2017, breast cancer segment is expected to account for largest share of global cancer/tumor profiling market.
1 Cancer Profiling Market: Overview
2 Geographic Analysis: Cancer Profiling Market, By Technology (2017)
3 Cancer Profiling Market, By Application
4 Cancer Profiling Market, By Hybridization Technology
5 Geographical Snapshot of the Cancer Profiling Market
Major players operating in cancer profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies like acquisitions, agreements, & collaborations and organic strategies like product launches & expansions to sustain their growth in cancer profiling market.
Click now for more information on this research of “Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022” report @ www.reportsnreports.com/contacts/d….aspx?name=268825 .
Objectives of the Study
- To define, describe, and forecast the cancer/tumor profiling market on the basis of application, technology, cancer type, and region.
- To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market.
- To analyze the opportunities in the market for stakeholders and details of a competitive landscape for market leaders.
- To forecasting the revenue of market segments with respect to four main geographies (along with countries), namely, North America, Europe, Asia Pacific, and the RoW.
- To profile key players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as collaborations, new product developments, product enhancements, and R&D activities in the cancer/tumor profiling market.